Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April –– 89% CR, two-year lo...
Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April –– 89% CR, two-year lo...
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) released its earnings results on Monday. The company reported ($0.13) EPS for the quarter, meeting the consensus estimate of ($0.13), MarketWatch Earnings reports. Alpha Tau Medical Stock Performance DRTS opened at $3.25 on Tuesday. The firm has a market capitalization of $224.67 million, a PE ratio of […]
– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR, two-year local recurrence-free survival of 77%, and no...
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation. Institutional and Insider Ownership […]
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation. Risk & Volatility Alpha […]